In-haled salbutamol versus salbutamol with budesonide in acute asthma in children - RCT
Not Applicable
- Conditions
- Health Condition 1: J459- Other and unspecified asthma
- Registration Number
- CTRI/2023/07/054636
- Lead Sponsor
- PONDICHERRY INSITUTE OF MEDICAL SCIENCIES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Child aged 2 yrs to 15 years with acute exacerbation of bronchial asthma.
Exclusion Criteria
A. Asthmatic Children who had received any form corticosteroid therapy in less
than 24 hours from the time of admission
B. Children who had received salbutamol in the last 6 hours.
C. Children with known history of cardiovascular disease, chronic renal disease, chronic lung disease or diabetes mellitus, congenital anomalies, genetic or metabolic
disorders.
D. Children with known allergy to corticosteroids
E. Children with Oral candidiasis
F. Children with known systemic hypertension
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o distress <br/ ><br>No wheeze <br/ ><br>No dyspnea <br/ ><br>SpO2 95% <br/ ><br>No pulses paradoxus <br/ ><br>Timepoint: Response sustained 60 minutes after the last treatment
- Secondary Outcome Measures
Name Time Method To compare the duration of intensive care stay among <br/ ><br>children aged 2-15 years with acute exacerbation of bronchial asthma among <br/ ><br>both groups.Timepoint: after 6 hours